A team recognized for their high laboratory standards received a grant to develop a device that could eliminate the need for glucose testing and insulin injections to manage diabetes.

In the Romanoski Lab, a graduate student simulates blood flow in a petri dish to learn why some people are more susceptible to heart disease.

Researchers say the genetically engineered stem cells also could pave the way for new regenerative medicine treatments for diseases such as Type 1 diabetes.

Detecting the neurodegenerative disease at an earlier stage might open doors to more effective and targeted treatments.

Researchers hope to “rejuvenate” the aging immune system by repairing lymph nodes.

A Nov. 3 event will feature presentations on Valley fever risk mitigation, vaccines, policy measures, strategies for cooperation among states and more.

Specialized cells take out the trash in the brain. When they break down, waste builds up, possibly setting the stage for Alzheimer’s disease.

Researchers at the Center for Innovation in Brain Science received a $1.4 million Translational Research in Alzheimer’s Disease and Related Dementias grant.

The startup Ancerix is working to commercialize much-needed instruments for surgical hardware removal. The team worked with Tech Launch Arizona to file patents and license its intellectual property.

For four decades, John Galgiani, MD, has pioneered translational research and clinical care for Valley fever, a disease more common in Arizona than anywhere else.